OXOS Medical’s MC2 secures clearance for paediatric imaging
OXOS Medical has received the US Food and Drug Administration (FDA) clearance for the MC2 portable X-ray for paediatric imaging. The …
OXOS Medical has received the US Food and Drug Administration (FDA) clearance for the MC2 portable X-ray for paediatric imaging. The …
Innovation agency Enterprise Ireland has signed a new alliance with Northwell Health, intended to advance commercialisation activities for Irish life …
CMR Surgical has joined an NVIDIA-led initiative centred on advancing the artificial intelligence (AI) capabilities of surgical robots. The British surgical …
Lensar has announced the termination of its planned acquisition by Alcon, citing unresolved regulatory concerns as the main reason for …
L&T Technology has launched its NVIDIA-powered AI digital twin platform for lung navigation, surgical planning, and respiratory diagnostics. The platform integrates …
Intuitive disclosed late last week that it was impacted by a ‘targeted cybersecurity phishing incident’ yet emphasised that neither its …
Neuracle Technology has received marketing approval from China’s National Medical Products Administration (NMPA) for its invasive brain-computer interface (BCI) device. The …
KORU Medical has received the European Union Medical Devices Regulation (EU MDR) certification for its Freedom60 infusion pump, including an …
Insulet has initiated a voluntary recall for certain lots of its Omnipod 5 pods following 18 serious adverse event (AE) …
Stryker is continuing to deal with the fallout from a cyberattack that an Iran-linked hacktivist group Handala has claimed responsibility …
While these transfers are a normal part of business, navigating them requires a strategic approach to ensure smooth and efficient …
Dexcom is poised to share new data on the benefits of its continuous glucose monitoring technology (CGM), which the company …
Johnson & Johnson (J&J) has received approval from the US Food and Drug Administration (FDA) for its TECNIS PureSee extended …
Abbott has announced results from the FreeDM2 randomised controlled trial (RCT), indicating that improved glucose outcomes were observed in individuals …
US-based Verve Medical has reported the treatment of the first patient in its pilot trial for uncontrolled hypertension with a renal …